|
|
|
|
|
Received: 14 September 2011
|
|
|
|
| ［1］ |
胡亚美，江载芳.诸福棠实用儿科学［M］，7版，北京：人民卫生出版社，2002： 2184-2185.
|
| ［1］ |
胡亚美，江载芳.诸福棠实用儿科学［M］，7版，北京：人民卫生出版社，2002： 2184-2185.
|
| [2] |
高解春. 21世纪小儿肿瘤研究展望和防治理念［J］. 中国肿瘤， 2001，10(10):5-7.
|
| [2] |
高解春. 21世纪小儿肿瘤研究展望和防治理念［J］. 中国肿瘤， 2001，10(10):5-7.
|
| [3] |
Nagaraj S, Ziske C, Schmidt-Wolf I G. Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer［J］. Genet Vaccines Ther, 2004,2(1):12 .
|
| [3] |
Nagaraj S, Ziske C, Schmidt-Wolf I G. Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer［J］. Genet Vaccines Ther, 2004,2(1):12 .
|
| [4] |
Levin D, Constant S, Pasqualini T, et al. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo［J］. Immunol, 1993,151(12):6742-6750.
|
| [4] |
Levin D, Constant S, Pasqualini T, et al. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo［J］. Immunol, 1993,151(12):6742-6750.
|
| [5] |
Tuyaerts S, Van Meirvenne S, Bonehill A，et al. Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells［J］. Leukoc Biol, 2007,82(1):93-105.
|
| [5] |
Tuyaerts S, Van Meirvenne S, Bonehill A，et al. Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells［J］. Leukoc Biol, 2007,82(1):93-105.
|
| [6] |
李世俊, 张连生, 柴 晔, 等. 树突状细胞与细胞因子诱导的杀伤细胞共培养对多药耐药肿瘤细胞系的杀伤活性［J］.中华肿瘤杂志， 2007,23(10):733-737.
|
| [7] |
Sheng K C, Pietersz G A, Wright M D, et al. Dendritic cells: activation and maturation—applications for cancer immunotherapy［J］.Curr MedChem， 2005 ,12(15):1783-1800.
|
| [8] |
Schmidt-Wolf I G, Lefterova P, Mehta B A, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine -induced killer cells［J］. Exp Hematol, 1993,21(13):1673-1679.
|
| [6] |
李世俊, 张连生, 柴 晔, 等. 树突状细胞与细胞因子诱导的杀伤细胞共培养对多药耐药肿瘤细胞系的杀伤活性［J］.中华肿瘤杂志， 2007,23(10):733-737.
|
| [9] |
Zoll B, Lefterova P, Csipai M, et al. Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or-12［J］. Cancer Immunol Immunother,1998，47(4):221-226.
|
| [7] |
Sheng K C, Pietersz G A, Wright M D, et al. Dendritic cells: activation and maturation—applications for cancer immunotherapy［J］.Curr MedChem， 2005 ,12(15):1783-1800.
|
| [10] |
Alvarnas J C, Linn Y C, Hope E G, et al. Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation［J］. Biol Blood Marrow Transplant, 2001,7(4):216-222.
|
| [11] |
Mehta B A, Schmidt-Wolf I G, Weissman I L, et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells［J］. Blood, 1995,86(9):3493-3499.
|
| [8] |
Schmidt-Wolf I G, Lefterova P, Mehta B A, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine -induced killer cells［J］. Exp Hematol, 1993,21(13):1673-1679.
|
| [12] |
Linn Y C, Wang S M, Hui K M. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays［J］. Exp Hematol, 2005,33(6):671-681.
|
| [9] |
Zoll B, Lefterova P, Csipai M, et al. Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or-12［J］. Cancer Immunol Immunother,1998，47(4):221-226.
|
| [10] |
Alvarnas J C, Linn Y C, Hope E G, et al. Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation［J］. Biol Blood Marrow Transplant, 2001,7(4):216-222.
|
| [13] |
CEN Xinan, ZHU Ping, SHI Yongjin, et al. Cytokine-induced killer cells induce apoptosis of K562 cells expressed bcr-abl［J］. Zhong Guo Shi Yan Xue Ye Xue Za Zhi, 2002,10(3):201-204.
|
| [11] |
Mehta B A, Schmidt-Wolf I G, Weissman I L, et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells［J］. Blood, 1995,86(9):3493-3499.
|
| [14] |
Cooper M A, Fehniger T A, Fuchs A, et al. NK cell and DC interactions［J］. Trends Immunol, 2004,25(1):47-52.
|
| [12] |
Linn Y C, Wang S M, Hui K M. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays［J］. Exp Hematol, 2005,33(6):671-681.
|
| [15] |
Lau A H, Thomson A W. Dendritic cells and immune regulation in the liver［J］. Gut, 2003,52(2):307-314.
|
| [13] |
CEN Xinan, ZHU Ping, SHI Yongjin, et al. Cytokine-induced killer cells induce apoptosis of K562 cells expressed bcr-abl［J］. Zhong Guo Shi Yan Xue Ye Xue Za Zhi, 2002,10(3):201-204.
|
| [16] |
魏绪仓,翟欣辉,韩秀蕊，等.脐血树突细胞对同源CIK细胞生物活性及抗白血病作用影响的研究［J］.中国实验血液学杂志,2010,18(4):946-951.
|
| [17] |
张倩倩，李锦毅.DC与CIK抗肿瘤作用的研究进展［J］.中国实用药,2008,3(9):128-129.
|
| [14] |
Cooper M A, Fehniger T A, Fuchs A, et al. NK cell and DC interactions［J］. Trends Immunol, 2004,25(1):47-52.
|
| [18] |
刘 苗,徐佳伟,金润铭.细胞因子诱导的白血病杀伤细胞的体外生物活性［J］.实用儿科临床杂志,2010,25(15):1144-1147.
|
| [15] |
Lau A H, Thomson A W. Dendritic cells and immune regulation in the liver［J］. Gut, 2003,52(2):307-314.
|
| [19] |
刘 苗,金润铭,姜 毅.树突细胞联合细胞因子诱导的杀伤细胞生物学特性和体外杀瘤机制［J］. 实用儿科临床杂志, 2011,26(1):35-38.
|
| [16] |
魏绪仓,翟欣辉,韩秀蕊，等.脐血树突细胞对同源CIK细胞生物活性及抗白血病作用影响的研究［J］.中国实验血液学杂志,2010,18(4):946-951.
|
| [17] |
张倩倩，李锦毅.DC与CIK抗肿瘤作用的研究进展［J］.中国实用药,2008,3(9):128-129.
|
| [18] |
刘 苗,徐佳伟,金润铭.细胞因子诱导的白血病杀伤细胞的体外生物活性［J］.实用儿科临床杂志,2010,25(15):1144-1147.
|
| [19] |
刘 苗,金润铭,姜 毅.树突细胞联合细胞因子诱导的杀伤细胞生物学特性和体外杀瘤机制［J］. 实用儿科临床杂志, 2011,26(1):35-38.
|
|
|
2012, Vol. 23 
